Rare diseases
Investigational molecules
Locations
Rupnicu Iela 5, 2114, Latvia
Olpha AS is active in clinical research focused on atrial fibrillation, with interest in treatments aimed at maintaining sinus rhythm and supporting rhythm control in patients with irregular heart rhythms.
The sponsor’s research activity reflects a therapeutic focus on cardiovascular medicine, particularly the management of rhythm disturbances using established antiarrhythmic agents.
Olpha AS runs clinical trials in conditions such as Atrial fibrillation, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
LatviaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
